Veriheal

DECEMBER 27, 2022

Let’s dive into what the research says about these promising new findings and how they might advance the field of psychedelic research. Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. The subjective nature of self-reported data can plague research.

Research and Development 95

Research and Development Therapy Consumption DEA 95

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law. The final part of the resolution discusses the need to support research into cannabis.

Policy 40

Policy Research and Development Marijuana DEA 40

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits. The Natural Medicine Health Act: Pros and Cons.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. The panel would center on the evolution of cannabis policy in the U.S.,

Research and Development 52

Research and Development Events Topical Policy 52

Cannabis Law Report

JULY 23, 2021

Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Research, Training and Prevention.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Cannabis Law Report

JULY 1, 2021

On June 30th, the Petrie-Flom Center announced the launch of a three-year research initiative , the Project on Psychedelics Law and Regulation (POPLAR) , which is supported by a generous grant from the Saisei Foundation. POPLAR will publish original law and policy research.

Law 105

Law Research and Development Therapy DEA 105

Canna Law Blog

NOVEMBER 6, 2021

Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. But only if it is made affordable and accessible.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Executive Summary. Marijuana Possession for Personal Use.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

NOVEMBER 2, 2021

This is a well researched and detailed report and is, we suggest required reading. The investigation covered a lot of important ground, but the main results concern the levels of delta-9 THC in each product, the inaccuracy of the labeling, how easily minors can get access to products and whether companies test for impurities.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

SEPTEMBER 1, 2021

3] Further, notwithstanding the determination of the Drug Enforcement Administration (DEA), which is required to defer to the Department of Health and Human Services’ assessment that cannabis has no acceptable medical utility, 37 states and four territories have enacted laws allowing for the medical use of cannabis products. [4] Gordon Gray.

Policy 100

Policy Cannabis Treatment Law 100

Canna Law Blog

MARCH 4, 2020

With respect to ketamine infusion therapy (which is the prime time attraction of ketamine clinics), the medical research based promise is for treatment of chronic neuropathic pain, chronic pain (instead of opioids), and various medication-resistant mental health disorders, including depression, bi-polar disorder, and PTSD (among others).

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Project CBD

AUGUST 23, 2023

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. Marketing to Minors Unlike state-regulated cannabis, this new wave of acutely intoxicating substances is easily accessible to minors. percent on a dry weight basis.”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Cannabis Law Report

JUNE 1, 2021

Operating expenses : Total SG&A (“SG&A”) expenses in Q4 2021 declined by 25% versus Q4 2020, driven by year-over-year reductions in Sales & Marketing, and Research and Development (“R&D”) expenses. A replay will be accessible by webcast until 11:59 PM ET on August 30, 2021 at: [link].

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Rick Doblin founded MAPS as an official 501(c)(3) non-profit research organization on April 8, 1986. Later that year, Doblin sued the DEA for the first time.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

SEPTEMBER 12, 2021

THC is the most prevalent, famous and researched cannabinoid by far. This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock).

THC 98

THC Research and Development Cannabinoids CBD 98

Sensi Seeds

NOVEMBER 28, 2018

But in an email correspondence conducted as research for this article, EFSA denies issuing any statement in relation to CBD in Spain. Irrespective of where the directive came from, policy on CBD has changed. Spanish companies must comply with the change in law, or face fines and/or product confiscation.

CBD 71

CBD Seed-To-Sale Food Research and Development 71

The Cannigma

FEBRUARY 16, 2022

Listen & Subscribe: In light of Black History Month, we feel it is important and relevant to talk about how minorities in the United States and around the world have been disproportionately affected by drug policy and the war on drugs. We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all.

Trichome 73

Trichome Wellness and Beauty Cannabinoids Cannabis 73

The Cannigma

MAY 15, 2023

Because ketamine promotes neuroplasticity, or in other words helps “rewire” the brain,” research shows that it can help stop the repetitive negative thoughts and behaviors that are at the core of many mental health conditions. In some instances, a medical provider or psychotherapist (or both) is present in the treatment room.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Cannabis Law Report

AUGUST 6, 2021

Operating expenses : Total SG&A (“SG&A”) expenses in Q1 2022 declined by 17% versus Q1 2021, driven by year-over-year reductions in General & Administrative (“G&A”) and Research and Development (“R&D”) expenses partially offset by an increase in Sales & Marketing (“S&M”) expenses. Webcast Information.

Vaping 105

Vaping Research and Development Data Business 105

The Blunt Truth

MAY 15, 2020

We’ve got an update on the latest Montana legalization developments. The news on access to loans and other support from the Small Business Administration was less rosy. marijuana research. No word yet on any change in policy. SBA funds, however, are not. There’s also lots of state news. cannabis banking.

Banking 106

Banking Research and Development Programs Advocacy 106

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

As policies become more data-driven and progressive, cultivation and production technologies have continued to improve drastically over the past several years. The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse.

Recreational 52

Recreational Data Cannabis DEA 52

SpeedWeed

DECEMBER 28, 2018

There’s nothing to justify the sky-high price (about $90 per day) beyond the cost of research and development to win FDA approval. But there’s nothing to justify the sky-high price (about $90 per day) beyond the cost of research and development to win FDA approval and Big Pharma’s insatiable thirst for profits.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

SEPTEMBER 19, 2019

As far as we know, Senate Majority Leader Mitch McConnell still isn’t willing to make even the slightest move toward legal weed; however, there have been some wicked, unforeseen developments. . Doctors say they look forward to seeing more research on the subject as more states allow marijuana in smokable form.

Vaping 55

Vaping Hemp Education Patients 55

Cannabis Law Report

JULY 30, 2019

Beasley is forced by default to expand her knowledge base through scientific facts that warrant closer inspection and through accessible existing research, with few current cannabis case studies. Most reliable medical cannabis research filters into the U.S. through international sources, namely Israel. . Federal Register. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

JULY 14, 2021

Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. Medical research will no longer be stifled.

Legislation 71

Legislation Banking History Access 71

Nature's Way Medicine

FEBRUARY 12, 2021

Cannabis stocks jumped last week after Chuck Schumer met with Senators Cory Booker and Ron Wyden and all three senators announced in a joint statement their commitment to developing a comprehensive marijuana reform bill. Cannabidiol and Marihuana Research Expansion Act. State News. Other News.

Research and Development 97

Research and Development Patients CBD DEA 97